These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5627157)

  • 1. [Symposium on clinical aspects on porphyrias. (4). The role of citric acid cycle turnover in the control of heme biosynthesis].
    Onisawa J
    Nihon Naika Gakkai Zasshi; 1967 Sep; 56(9):965-9. PubMed ID: 5627157
    [No Abstract]   [Full Text] [Related]  

  • 2. Permeability properties of mitochondrial membranes and the regulation of haem biosynthesis.
    Jones MS; Jones OT
    Biochem Biophys Res Commun; 1970 Nov; 41(4):1072-9. PubMed ID: 5477219
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biosynthesis of heme: regulation; hereditary and experimental porphyrias].
    Grandchamp B; Nordmann Y
    Expos Annu Biochim Med; 1980; 34():45-80. PubMed ID: 7009205
    [No Abstract]   [Full Text] [Related]  

  • 4. [Delta-aminolevulinic acid in physiological conditions and some diseases in children].
    Ziólkowska-Slupczyńska
    Pol Tyg Lek; 1974 Jan; 29(2):69-71. PubMed ID: 4820791
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oxidative phosphorylation in experimental hepatic porphyria].
    Panfil B; Dancewicz A
    Acta Physiol Pol; 1971; 22(6):846-8. PubMed ID: 5152824
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of decreased ferrochelatase activity on iron and porphyrin content in mitochondria of mice with porphyria induced by griseofulvin.
    Tangerås A
    Biochim Biophys Acta; 1986 Jun; 882(1):77-84. PubMed ID: 3707999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heme biosynthesis pathway and clinical manifestations of abnormal function.
    Phillips JD; Kushner JP
    Curr Protoc Toxicol; 2001 May; Chapter 8():Unit 8.1. PubMed ID: 20954154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haem biosynthesis and porphyrias: 50 years in retrospect.
    Rimington C
    J Clin Chem Clin Biochem; 1989 Aug; 27(8):473-86. PubMed ID: 2681520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Porphyrias : Metabolic disorders of heme biosynthesis].
    Frank J
    Hautarzt; 2016 Mar; 67(3):198-200. PubMed ID: 26743056
    [No Abstract]   [Full Text] [Related]  

  • 10. [The molecular basis and genetics of diseases associated with disorders of heme biosynthesis].
    Fuchs O
    Cas Lek Cesk; 1996 Jan; 135(2):54-8. PubMed ID: 8616881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental porphyrias as models for human hepatic porphyrias.
    De Matteis F; Stonard M
    Semin Hematol; 1977 Apr; 14(2):187-92. PubMed ID: 854763
    [No Abstract]   [Full Text] [Related]  

  • 12. Heme synthesis in protoporphyria.
    Bloomer JR; Hill HD; Kools AM; Straka JG
    Curr Probl Dermatol; 1991; 20():135-47. PubMed ID: 1935205
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme defects in the porphyrias and their relevance to the biochemical abnormalities in these disorders.
    Bloomer JR
    J Invest Dermatol; 1981 Jul; 77(1):102-6. PubMed ID: 7252240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intermittent acute porphyria. Hepatic ultrastructural study].
    Gaultier M; Gervais P; Bescol J; Conso F; Aubry P; Guillam C
    Ann Med Interne (Paris); 1974; 125(6-7):539-46. PubMed ID: 4440969
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemically induced porphyria: increased microsomal heme turnover after treatment with allylisopropylacetamide.
    Meyer UA; Marver HS
    Science; 1971 Jan; 171(3966):64-6. PubMed ID: 5538700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of the porphyrias: mechanisms of action.
    Bickers DR
    J Invest Dermatol; 1981 Jul; 77(1):107-13. PubMed ID: 7252241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyrin biosynthesis. Enhancement of the fractional catabolic rate of microsomal haem in chemically induced porphyria.
    Meyer UA; Marver HS
    S Afr Med J; 1971 Sep; ():175-7. PubMed ID: 5150273
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurotoxic aspects of porphyrinopathies: lead and succinylacetone.
    Silbergeld EK; Hruska RE; Bradley D; Lamon JM; Frykholm BC
    Environ Res; 1982 Dec; 29(2):459-71. PubMed ID: 7160360
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathobiochemistry of porphyrias].
    Doss M
    Med Klin; 1977 Sep; 72(38):1501-18. PubMed ID: 333255
    [No Abstract]   [Full Text] [Related]  

  • 20. The pattern of urinary citric acid cycle and related acids in experimental porphyria in the rat.
    Vaughn CB; Orten JM
    Biochim Biophys Acta; 1969 May; 177(3):647-9. PubMed ID: 5787256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.